| Fund ID | 805-7380401778 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 4% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 75% |
| Fund | Type | Gross assets |
|---|---|---|
| Silicon Catalyst Venture Fund LLC | Venture Capital | $100M |
| Ocryptofund LLC | Private Equity | $23.7M |
| Oceaniq Partners Fund II | Venture Capital | $17.6M |
Wisdomont Biotech Fund LLC reports $339,831 in gross assets, among the top 97% of private funds by size.
The stated minimum investment is $25,000.
Wisdomont Biotech Fund LLC is managed by Oceaniq Capital, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.